Results 71 to 80 of about 2,819,150 (289)

Characterizing Parental Concerns About Lasting Impacts of Treatment in Children With B‐Acute Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background B‐acute lymphoblastic leukemia (B‐ALL) is the most common pediatric cancer, and while most children in high‐resource settings are cured, therapy carries risks for long‐term toxicities. Understanding parents’ concerns about these late effects is essential to guide anticipatory support and inform evolving therapeutic approaches ...
Kellee N. Parker   +7 more
wiley   +1 more source

Ensuring Ethical Dental Care: Obtaining Legal Consent for Nonverbal Adults

open access: yesJournal of the California Dental Association, 2023
TDIC Risk Management Staff
doaj   +1 more source

Clinical Characteristics and Prognostic Risk Factors for Pediatric B‐Cell Lymphoblastic Lymphoma: A Multicenter Retrospective Cohort Study for China Net Childhood Lymphoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background B‐cell lymphoblastic lymphoma (B‐LBL) represents a rare variety of non‐Hodgkin lymphoma, with limited research on its biology, progression, and management. Methods A retrospective analysis was performed on the clinical characteristics of 256 patients aged ≤18 years who received treatment under the China Net Childhood Lymphoma (CNCL)‐
Zhijuan Liu   +20 more
wiley   +1 more source

THE IMPACT OF DOWNSIZING ON THE BANKRUPTCY OF RUSSIAN COMPANIES

open access: yesСтратегические решения и риск-менеджмент, 2019
Links between staff reductions and the company’s bankruptcyare identified. The empirical base of research included 650 companies (150 bankrupts) in the manufacturing industry and 1,500 companies (410 bankrupts) in the construction industry.
E. A. Fedorova, V. S. Strelkov
doaj   +1 more source

Exercise Interventions in Children, Adolescents and Young Adults With Paediatric Bone Tumours—A Systematic Review

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Bone tumours present significant challenges for affected patients, as multimodal therapy often leads to prolonged physical limitations. This is particularly critical during childhood and adolescence, as it can negatively impact physiological development and psychosocial resilience.
Jennifer Queisser   +5 more
wiley   +1 more source

Risk Management Through Systematization: Risk Management Culture

open access: yesInternational Journal of Recent Technology and Engineering (IJRTE), 2019
Risks always accompany any possible type of activity, it is a complex economic concept, without an effective management system which it is impossible to imagine the functioning of a modern enterprise. Close attention has always been paid to the creation and improvement of the risk management system, while the very nature of this economic category ...
Svitlana Filyppova*   +5 more
openaire   +1 more source

On Evidence-based Risk Management in Requirements Engineering

open access: yes, 2017
Background: The sensitivity of Requirements Engineering (RE) to the context makes it difficult to efficiently control problems therein, thus, hampering an effective risk management devoted to allow for early corrective or even preventive measures ...
B Boehm   +15 more
core   +1 more source

Predicting the Future Burden of Renal Replacement Therapy in Türkiye Using National Registry Data and Comparative Modeling Approaches

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic kidney disease is a growing public health problem worldwide, and the number of patients requiring renal replacement therapy is steadily increasing. Türkiye has experienced a similar rise in both the incidence and prevalence of renal replacement therapy over the past decades; however, national‐level projections of future ...
Arzu Akgül   +2 more
wiley   +1 more source

Medication Risk Management

open access: yesINNOVATIONS in pharmacy, 2019
Historically, the FDA has interpreted the requirement that a drug must be “safe” to mean that the benefits of a drug outweigh its risks. The determination was made on a “categorical” basis, where the totality of risks was weighted against the totality of benefits when considered for the purposes outlined in the drug product’s labeling.
openaire   +3 more sources

Home - About - Disclaimer - Privacy